Carbimazole-Resistant Grave’s Thyrotoxicosis is a Diagnostic and Therapeutic Dilemma, Case Report with Literature Review

BACKGROUND: Carbimazole (CBZ) (or methimazole) is the most used drug inducing and maintaining remission in thyrotoxicosis, especially Grave’s disease (GD). Rarely, situations arise when patients do not respond to recommended or even supratherapeutic doses of CBZ. It poses a challenge to diagnose dru...

Descripción completa

Detalles Bibliográficos
Autores principales: Ata, Fateen, Khan, Adeel Ahmad, Tahir, Shuja, Al Amer, Zaina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693278/
https://www.ncbi.nlm.nih.gov/pubmed/38046545
http://dx.doi.org/10.2147/IMCRJ.S429561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693278/
https://www.ncbi.nlm.nih.gov/pubmed/38046545
http://dx.doi.org/10.2147/IMCRJ.S429561

Ejemplares similares